scholarly journals Immunological monitoring for prediction of clinical response to antitumor vaccine therapy

Oncotarget ◽  
2018 ◽  
Vol 9 (36) ◽  
pp. 24381-24390 ◽  
Author(s):  
Irina N. Mikhaylova ◽  
Irina Zh. Shubina ◽  
George Z. Chkadua ◽  
Natalia N. Petenko ◽  
Lidia F. Morozova ◽  
...  
2017 ◽  
Vol 24 (5) ◽  
pp. 1190-1201 ◽  
Author(s):  
Elizabeth K. Duperret ◽  
Aspen Trautz ◽  
Dylan Ammons ◽  
Alfredo Perales-Puchalt ◽  
Megan C. Wise ◽  
...  

2013 ◽  
Vol 10 (2) ◽  
pp. 338-343 ◽  
Author(s):  
Shiro Suzuki ◽  
Shiro Suzuki ◽  
Kiyosumi Shibata ◽  
Kiyosumi Shibata ◽  
Fumitaka Kikkawa ◽  
...  

2004 ◽  
Vol 111 (4) ◽  
pp. 575-583 ◽  
Author(s):  
Delphine Massé ◽  
Frédéric Ebstein ◽  
Gwenola Bougras ◽  
Jean Harb ◽  
Khaled Meflah ◽  
...  

2004 ◽  
Vol 4 (10) ◽  
pp. 1677-1684 ◽  
Author(s):  
Dirk Nagorsen ◽  
Carmen Scheibenbogen ◽  
Eckhard Thiel ◽  
Ulrich Keilholz

2010 ◽  
Vol 20 (3) ◽  
pp. 76-83 ◽  
Author(s):  
Joseph Donaher ◽  
Tom Gurrister ◽  
Irving Wollman ◽  
Tim Mackesey ◽  
Michelle L. Burnett

Parents of children who stutter and adults who stutter frequently ask speech-language pathologists to predict whether or not therapy will work. Even though research has explored risk-factors related to persistent stuttering, there remains no way to determine how an individual will react to a specific therapy program. This paper presents various clinicians’answers to the question, “What do you tell parents or adults who stutter when they ask about cure rates, outcomes, and therapy efficacy?”


2001 ◽  
Vol 120 (5) ◽  
pp. A253-A253
Author(s):  
V YANG ◽  
R CASERO ◽  
D GEIMAN ◽  
W HUBBARD ◽  
L HYLIND ◽  
...  
Keyword(s):  

2006 ◽  
Vol 175 (4S) ◽  
pp. 201-201 ◽  
Author(s):  
Isao Hara ◽  
Junya Furukawa ◽  
Kazuki Yamanaka ◽  
Yuji Yamada ◽  
Masato Fujisawa

Sign in / Sign up

Export Citation Format

Share Document